Vipulbhai Sakhiya

发表

Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancer.

S. Fishbane, R. Wanchoo, H. Shah, 2014 .

Pregnancy outcomes in women on hemodialysis: a national survey

I. Miller, Vipulbhai Sakhiya, Mala Sachdeva, 2017, Clinical kidney journal.

Longitudinal predictors of uremic pruritus.

S. Fishbane, S. Shirazian, D. Moledina, 2013, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Acute kidney injury in patients hospitalized with COVID-19

Kenar D. Jhaveri, Jamie S. Hirsch, Hitesh H. Shah, 2020, Kidney International.

Nephrotoxicity of the BRAF Inhibitors Vemurafenib and Dabrafenib.

S. Fishbane, K. Jhaveri, Vipulbhai Sakhiya, 2015, JAMA oncology.

Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative Review

S. Fishbane, Daniel W. Ross, K. Jhaveri, 2016, Kidney international reports.

Clinicopathologic Features of Acute Kidney Injury Associated With CDK4/6 Inhibitors

Shruti Gupta, T. Caza, K. Jhaveri, 2021, Kidney international reports.

Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury

M. Abate, P. Singhal, S. Fishbane, 2020, American Journal of Kidney Diseases.

Serum potassium laboratory reference ranges influence provider treatment behaviors for hyperkalemia.

S. Fishbane, K. Jhaveri, J. Hirsch, 2020, Nephrology, Dialysis and Transplantation.

Renal effects of novel anticancer targeted therapies: a review of the Food and Drug Administration Adverse Event Reporting System.

S. Fishbane, Daniel W. Ross, K. Jhaveri, 2016, Kidney international.

Immune checkpoint inhibitor-associated electrolyte disorders: query of the Food and Drug Administration Adverse Event Reporting System.

K. Jhaveri, R. Wanchoo, Vipulbhai Sakhiya, 2021, Kidney international.

Prevalence and outcomes of hyponatremia and hypernatremia in patients hospitalized with COVID-19

M. Abate, P. Singhal, S. Fishbane, 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Outcomes of patients with end-stage kidney disease hospitalized with COVID-19

M. Abate, P. Singhal, S. Fishbane, 2020, Kidney International.

Augmented Nurse Care Management in CKD Stages 4 to 5: A Randomized Trial.

S. Fishbane, H. Shah, L. Balsam, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The Relationship Between Medication Discrepancies and Hospitalization Risk Among Patients With Advanced CKD

S. Fishbane, K. Jhaveri, Meng Zhang, 2019, Kidney international reports.

Medication discrepancies in late-stage chronic kidney disease

Meng Zhang, S. Fishbane, A. Mathew, 2017, Clinical kidney journal.

Ibrutinib induced acute tubular injury: A case series and review of the literature

S. Manohar, K. Jhaveri, R. Wanchoo, 2019, American journal of hematology.

Capillary leak syndrome with immune checkpoint inhibitors and anti-cancer targeted therapy agents: Not that common

K. Jhaveri, R. Wanchoo, Vipulbhai Sakhiya, 2023, Journal of Onco-Nephrology.

Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Prospective Observational Study.

S. Fishbane, Daniel W. Ross, K. Jhaveri, 2020, Kidney360.

Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Mellitus and CKD

S. Fishbane, K. Jhaveri, Meng Zhang, 2019, Kidney medicine.

Longitudinal predictors of uremic pruritus.

S. Fishbane, A. Hazzan, Vipulbhai Sakhiya, 2013, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Nephrotoxicity of the BRAF Inhibitors Vemurafenib and Dabrafenib.

S. Fishbane, K. Jhaveri, Vipulbhai Sakhiya, 2015, JAMA oncology.